| Dr Joseph E Slawek, MD | |
|
210 Ark Rd, Mount Laurel, NJ 08054-3188 | |
| (856) 778-8860 | |
| (609) 261-4180 |
| Full Name | Dr Joseph E Slawek |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 33 Years |
| Location | 210 Ark Rd, Mount Laurel, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629070016 | NPI | - | NPPES |
| 7402309 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 25MA06560800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Larchmont Imaging Associates Llc | 5193762433 | 23 |
| Radiology Associates Of Burlington County, P.a. | 7012954381 | 56 |
| South Jersey Radiology Associates, P.a. | 9133115587 | 60 |
News Archive
A Loyola University Chicago study published this month has found an increase in the percentage of breast cancer patients who were diagnosed in early Stage 1, after the Affordable Care Act took effect.
Champions Biotechnology, Inc. announced today that it has exercised an option to license Irinophore C, a liposomal formulation of Irinotecan, from the BC Cancer Agency in British Columbia, Canada.
The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metastatic solid tumours were reported today at the ESMO 2016 Congress in Copenhagen.
The American Society for Radiation Oncology's education credentials have been recognized and upgraded by the Accreditation Council for Continuing Medical Education from Accreditation to Accreditation with Commendation, approved at the ACCME's December 2014 meeting.
› Verified 7 days ago
| Entity Name | South Jersey Radiology Associates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477551653 PECOS PAC ID: 9133115587 Enrollment ID: O20040422000102 |
News Archive
A Loyola University Chicago study published this month has found an increase in the percentage of breast cancer patients who were diagnosed in early Stage 1, after the Affordable Care Act took effect.
Champions Biotechnology, Inc. announced today that it has exercised an option to license Irinophore C, a liposomal formulation of Irinotecan, from the BC Cancer Agency in British Columbia, Canada.
The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metastatic solid tumours were reported today at the ESMO 2016 Congress in Copenhagen.
The American Society for Radiation Oncology's education credentials have been recognized and upgraded by the Accreditation Council for Continuing Medical Education from Accreditation to Accreditation with Commendation, approved at the ACCME's December 2014 meeting.
› Verified 7 days ago
| Entity Name | Larchmont Imaging Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710932603 PECOS PAC ID: 5193762433 Enrollment ID: O20050408000523 |
News Archive
A Loyola University Chicago study published this month has found an increase in the percentage of breast cancer patients who were diagnosed in early Stage 1, after the Affordable Care Act took effect.
Champions Biotechnology, Inc. announced today that it has exercised an option to license Irinophore C, a liposomal formulation of Irinotecan, from the BC Cancer Agency in British Columbia, Canada.
The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metastatic solid tumours were reported today at the ESMO 2016 Congress in Copenhagen.
The American Society for Radiation Oncology's education credentials have been recognized and upgraded by the Accreditation Council for Continuing Medical Education from Accreditation to Accreditation with Commendation, approved at the ACCME's December 2014 meeting.
› Verified 7 days ago
| Entity Name | Radiology Associates Of Burlington County, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255385183 PECOS PAC ID: 7012954381 Enrollment ID: O20050408000763 |
News Archive
A Loyola University Chicago study published this month has found an increase in the percentage of breast cancer patients who were diagnosed in early Stage 1, after the Affordable Care Act took effect.
Champions Biotechnology, Inc. announced today that it has exercised an option to license Irinophore C, a liposomal formulation of Irinotecan, from the BC Cancer Agency in British Columbia, Canada.
The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metastatic solid tumours were reported today at the ESMO 2016 Congress in Copenhagen.
The American Society for Radiation Oncology's education credentials have been recognized and upgraded by the Accreditation Council for Continuing Medical Education from Accreditation to Accreditation with Commendation, approved at the ACCME's December 2014 meeting.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph E Slawek, MD 1295 Route 38, P.o. Box 479, Hainesport, NJ 08036-2702 Ph: (609) 261-7017 | Dr Joseph E Slawek, MD 210 Ark Rd, Mount Laurel, NJ 08054-3188 Ph: (856) 778-8860 |
News Archive
A Loyola University Chicago study published this month has found an increase in the percentage of breast cancer patients who were diagnosed in early Stage 1, after the Affordable Care Act took effect.
Champions Biotechnology, Inc. announced today that it has exercised an option to license Irinophore C, a liposomal formulation of Irinotecan, from the BC Cancer Agency in British Columbia, Canada.
The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metastatic solid tumours were reported today at the ESMO 2016 Congress in Copenhagen.
The American Society for Radiation Oncology's education credentials have been recognized and upgraded by the Accreditation Council for Continuing Medical Education from Accreditation to Accreditation with Commendation, approved at the ACCME's December 2014 meeting.
› Verified 7 days ago
Dr. Howard S. Berinson, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 856-261-4500 Fax: 609-261-4180 | |
Dr. Nick Maravich, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 856-778-8860 Fax: 609-261-4180 | |
Dr. Robert T. Harvey, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 856-778-8860 Fax: 609-261-4180 | |
Dr. Britton Miller Chan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 Ark Road, Mount Laurel, NJ 08054 Phone: 609-914-7017 | |
Dr. Sungtae Lim, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 856-778-8860 Fax: 609-261-4180 | |
Dr. Priyesh Patel, M.D. Radiology Medicare: May Accept Medicare Assignments Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 609-261-4500 Fax: 609-261-4180 | |
Dr. Kevin P. Barry, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 Ark Rd, Mount Laurel, NJ 08054 Phone: 856-778-8860 Fax: 609-261-4180 |